Anthony N. Gerber

Anthony N. Gerber, MD, PhD

  • Department of Medicine
  • Division of Pulmonary, Critical Care and Sleep Medicine

Profile

Conditions Treated

  • Asthma
  • Autoimmune Lung Diseases
  • Chronic Cough
  • COPD

Research Areas

  • Asthma
  • Cellular and Molecular Biology
Gender:
Male

Education & Training

Education

1990
Massachusetts Institute of Technology, BS, Mathematics
1998
University of Washington, MD, PhD

Residency

1998-2000
University of California, San Francisco, Internal Medicine

Fellowship

2001-2004
University of California, San Francisco, Pulmonary and Critical Care

Special Interests

Research Interests

The glucocorticoid receptor is one of the most important therapeutic targets for the treatment of inflammatory disorders of the lung such as asthma. My laboratory investigates two aspects of glucocorticoid receptor signaling. First, we are studying the basic molecular mechanisms whereby glucocorticoids repress the expression of inflammatory genes in airway smooth muscle. Second, we are investigating how various non-inflammatory genes that are regulated by glucocorticoids alter lung function. By defining new mechanisms of glucocorticoid action we ultimately seek to discover new targets for asthma therapeutics.

Board Certification

Internal Medicine
Pulmonary Disease
Critical Care

Teaching or Professional Positions

No current positions.

Industry Relationships & Collaborations

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.

Affiliations with the University of Colorado Denver

Assistant Professor of Medicine
Graduate Faculty, Department of Pharmacology

Professional Memberships

American Thoracic Society
American Physiological Society
American Lung Association of Colorado

Publications

Sasse SK, Mailloux C, Barczak A, Wang Q, Altonsy O, Jain MK, Haldar SM and Gerber AN. The glucocorticoid receptor and KLF15 regulate gene expression dynamics and integrate signals through feed forward circuitry. Mol Cell Biol. 2013 Mar 18. [Epub ahead of print]

Haldar SM, Jeyaraj D, Anand P, Zhu H, Lu Y, Prosdocimo DA, Eapen B, Kawanami D, Okutsu M, Brotto L, Fujioka H, Kerner J, Rosca MG, McGuinness OP, Snow RJ, Russell AP, Gerber AN, Bai X, Yan Z, Nosek TM, Brotto M, Hoppel CL, Jain MK. Kruppel-like factor 15 regulates skeletal muscle lipid flux and exercise adaptation. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6739-44

Gerber A.N., Sutherland ER. Vitamin d and asthma: another dimension (Review). Am J Respir Crit Care Med. 2011 Dec 15;184(12):1324-5. PMID: 2217410

Masuno K, Haldar SM, Jeyaraj D, Mailloux C, Huang X, Panettieri Jr RA, Jain MK, Gerber A.N. 2011 Expression profiling identifies Klf15 as a glucocorticoid target that regulates Airway Hyperresponsiveness. Am J Respir Cell Mol Biol. 2011. Sep;45(3):642-9 PMCID: 21257922

Gerber, A.N., Masuno K., Diamond M.I.  2009. Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4929-34.

Website Information

Gerber Lab

Related Documents

Office Information

Doctor's Contact Information

  • Office: 877.225.5654
  • Email: gerbera@njhealth.org

Locations

  • Main Campus
    1400 Jackson St.
    Denver, CO 80206
    Main: 877.225.5654

Newsroom


In the Newsroom, you can find National Jewish Health press releases, newsletters, annual reports and media contacts. Learn more.